Centry Pharma
Fort Lee, US · Founded 2020 · Delaware corporation
Biotech
Founders & leadership
KH
Kenneth HobermanNamed on SEC filing
UB
Uri Ben-OrNamed on SEC filing
RB
Ron BentsurNamed on SEC filing
SS
Shay ShemeshNamed on SEC filing
JO
James OlivieroNamed on SEC filing
MK
Matthew KaplanNamed on SEC filing
EP
Enrique PoradosuNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$15.3M disclosed across 1 round · 2021
▶$15.3MraisedOct 2021 · 43 investors · PharmaceuticalsRule 506(b)
▶$15.3MraisedOct 2021 · 43 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth HobermanDirector
- Uri Ben-OrExecutive Officer
- Ron BentsurExecutive Officer, Director
- Shay ShemeshExecutive Officer
- James OlivieroDirector
- Matthew KaplanDirector
- Enrique PoradosuExecutive Officer
- Offering amount
- $15.3M
- Amount sold
- $15.3M
- Minimum investment
- $20K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Centry Pharma raised?
- Centry Pharma has disclosed $15.3M raised across 1 round.
- Where is Centry Pharma headquartered?
- Centry Pharma is headquartered in Fort Lee, US.